Developing Optimal Focal Muscle Vibration for Improving Spasticity

Status Completed

Clinical Trial Summary

The overall aim of the proposed study is to determine optimal parameter of focal muscle vibration for improving spasticity and identify neurophysiological mechanism in healthy subjects.

In investigation I-1, subjects will undergo focal muscle vibration with 40, 80, 120 Hz frequency at the medial gastrocnemius muscles (mGCM). As a surrogate maker of spasticity, H-reflex and compound motor action potential (CMAP) of the tibial nerve at mGCM will be recorded pre, during, and post vibration.

In investigation I-2, subjects will undergo focal muscle vibration with 0.1, 0.3, 0.5 mm amplitude at mGCM. H-reflex and CMAP of the tibial nerve at mGCM will be recorded pre, during, and post vibration.

In investigation II, subjects will undergo focal muscle vibration with predetermined parameters by the investigation I at mGCM. H-reflex and CMAP of the tibial nerve and motor evoked potential at mGCM will be recorded pre, during, and post vibration.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01915342
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Completed
Phase	N/A
Start date	August 2013
Completion date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04535479` - Dry Needling for Spasticity in Stroke	N/A
Completed	`NCT02907775` - Multi-channel Stimulation for Post Stroke Spasticity (MUSTS)	N/A
Recruiting	`NCT04530955` - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)	N/A
Active, not recruiting	`NCT03521076` - Randomized Controlled Trial of Virtual Reality	N/A
Completed	`NCT03080454` - The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke	Phase 1/Phase 2
Completed	`NCT02546999` - Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?	Phase 4
Active, not recruiting	`NCT01041157` - Botulinum Toxin Injection Efficiency	Phase 1
Terminated	`NCT00532532` - Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis	Phase 2
Terminated	`NCT00531466` - Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury	Phase 2
Completed	`NCT00535938` - MDs on Botox Utility (MOBILITY)	N/A
Completed	`NCT05546190` - A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
Recruiting	`NCT06117020` - Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals	Phase 1
Completed	`NCT01603628` - BOTOX® Treatment in Pediatric Lower Limb Spasticity	Phase 3
Completed	`NCT05510726` - Quantitative Evaluation of Muscle Stiffness in Neurological Patients With Muscle Overactivity
Not yet recruiting	`NCT04378946` - Error Augmentation Motor Learning Training Approach in Stroke Patients	N/A
Completed	`NCT01603615` - BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity	Phase 3
Completed	`NCT01251380` - Dysport® Pediatric Lower Limb Spasticity Follow-on Study	Phase 3
Completed	`NCT00549783` - BOTOX® Economic Spasticity Trial (BEST)	Phase 4
Completed	`NCT00210431` - Post Marketing Surveillance Study of Dysport
Completed	`NCT00076687` - Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function	Phase 2